SC
Soleus Capital Master Fund, L.P. disclosed a 8.1% stake in NVCR
Soleus Capital Master Fund, L.P. reported owning 8.1% of NovoCure Ltd (NVCR) (9,425,776 shares) in a Schedule 13G filed Nov 9, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.